235

45 - novembre 2018 - Minuti 22. SaslowD, SolomonD, LawsonHW, et al.; ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, AmericanSociety forColposcopy andCervical Pathology, andAmer- ican Society for Clinical Pathology screening guidelines for the pre- vention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147-172. 23. Moyer VA. Screening for cervical cancer: U.S. Preventive Serv- ices Task Force recommendation statement [published correction appears in Ann InternMed. 2013;158(11):852]. Ann InternMed. 2012;156(12):880-891. 24. American Academy of Family Physicians. Clinical preventive service recommendation. Cervical cancer. http://www.aafp.org/pa- tient-care/clinical-recommendations/all/cervical-cancer.html. Ac- cessed December 15, 2015. 25. U.S. Preventive Services Task Force. Colorectal cancer: screen- ing. October 2008. http://www.uspreventive services task force.org/Page/Document/Update Summary Final/colorectal-can- cer-screening? ds= 1&s=colorectal%20cancer. AccessedFebruary 16, 2016. 26. U.S. Preventive Services Task Force. Colorectal cancer: screen- ing. Draft recommendation. http://www.uspreventive services task force.org/Page/Document/Update SummaryDraft/colorectal-can- cer-screening2 ?ds=1&s=colorectal%20cancer. Accessed February 16, 2016. 27. American Academy of Family Physicians. Clinical preventive service recommendation. Colorectal cancer. http://www.aafp. org/pa- tient-care/clinical-recommendations/all/colorectal-cancer.html. Ac- cessed December 15, 2015. 28. LevinB, LiebermanDA,McFarlandB, et al. Screening and sur- veillance for the early detection of colorectal cancer and adenoma- tous polyps, 2008: a joint guideline from the American Cancer So- ciety, theUSMulti-SocietyTask Force onColorectal Cancer, and the AmericanCollege of Radiology. CACancer JClin. 2008;58(3):130- 160. 29. Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330-338. 30. Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States, 2015: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015;65(1):30-54. 31. American Academy of Family Physicians. Clinical preventive service recommendation. Lung cancer. http://www.aafp.org/patient- care/clinicalrecommendations/all/lung-cancer.html. Accessed De- cember 15, 2015. 32. Gates TJ. Screening for cancer: concepts and controversies. AmFamPhysician. 2014;90(9):625-631. 33. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. CochraneDatabase Syst Rev. 2013;(6):CD001877. 34. Independent UK Panel on Breast Cancer Screening. The ben- efits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778-1786. 35. U.S. Preventive ServicesTaskForce. Final recommendation state- ment. Breast cancer: screening. January 2016. http://www.uspre- ventive services task force.org/Page/Document /Recommendation Statement Final/breast-cancer-screening1. Accessed February 16, 2016. 36. NyströmL, Andersson I, BjurstamN, Frisell J, NordenskjöldB, Rutqvist LE. Long-term effects of mammography screening: up- dated overview of the Swedish randomised trials [published correc- tion appears in Lancet. 2002;360(9334):724]. Lancet. 2002;359(9310):909-919. 37. Badgwell BD, Giordano SH, Duan ZZ, et al. Mammography before diagnosis among women age 80 years and older with breast cancer. J ClinOncol. 2008;26(15):2482-2488. 38. McPherson CP, Swenson KK, Lee MW. The effects of mam- mographic detection and comorbidity on the survival of olderwomen with breast cancer. J AmGeriatr Soc. 2002;50(6):1061-1068. 39. McCarthyEP, Burns RB, FreundKM, et al.Mammography use, breast cancer stage at diagnosis, and survival among older women. J AmGeriatr Soc. 2000;48(10):1226-1233. 40. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Person- alizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann InternMed. 2011;155(1):10-20. 41. Barratt A, Howard K, Irwig L, Salkeld G, Houssami N. Model of outcomes of screening mammography: information to support informed choices. BMJ. 2005;330(7497):936. 42. Mandelblatt JS, CroninKA, Bailey S, et al.; Breast CancerWork- ing Group of the Cancer Intervention and Surveillance Modeling Network. Effects ofmammography screening under different screen- ing schedules: model estimates of potential benefits and harms [pub- lished correction appears in Ann Intern Med. 2010;152(2):136]. Ann InternMed. 2009;151(10):738-747. 43. Braithwaite D, Zhu W, Hubbard RA, et al.; Breast Cancer Surveillance Consortium. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013;105(5):334-341. 44. WelchHG, BlackWC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-613. 45. deGlasNA, KiderlenM, Bastiaannet E, et al. Postoperative com- plications and survival of elderly breast cancer patients: a FOCUS study analysis. Breast Cancer ResTreat. 2013;138(2):561-569. 46. MussHB,Woolf S, BerryD, et al.; Cancer andLeukemiaGroup B. Adjuvant chemotherapy inolder and younger womenwith lymph nodepositive breast cancer. JAMA. 2005;293(9):1073-1081. 47. BondM, PaveyT,Welch K, et al. Systematic review of the psy- chological consequences of false-positive screening mammograms. HealthTechnol Assess. 2013;17(13):1-170. 48. IlicD, NeubergerMM, DjulbegovicM, DahmP. Screening for prostate cancer. CochraneDatabase Syst Rev. 2013;(1):CD004720. 49. Andriole GL, Crawford ED, Grubb RL III, et al.; PLCOProj- ectTeam. Prostate cancer screening in the randomizedProstate, Lung, Colorectal, andOvarianCancer ScreeningTrial: mortality results af- ter 13 years of follow-up. JNatl Cancer Inst. 2012;104(2):125-132. 50. Schröder FH, Hugosson J, Roobol MJ, et al.; ERSPC Investi- gators. Prostate-cancermortality at 11 years of follow-up [published